{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:48:02Z","timestamp":1782110882719,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005153","name":"China National Funds for Distinguished Young Scientists","doi-asserted-by":"publisher","award":["82303439"],"award-info":[{"award-number":["82303439"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["23xkjc018"],"award-info":[{"award-number":["23xkjc018"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218507","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:15:15Z","timestamp":1776172515000},"page":"218507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TGF\u03b2-SMAD2\/3 signaling inhibits IRF2 to drive metastasis in KRAS-mutant colorectal cancer"],"prefix":"10.1016","volume":"650","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3159-9233","authenticated-orcid":false,"given":"Feng","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4904-346X","authenticated-orcid":false,"given":"Shi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-3134","authenticated-orcid":false,"given":"Wenting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8272-2450","authenticated-orcid":false,"given":"Y.","family":"Alan Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218507_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2026.218507_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218507_bib3","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Lievre","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218507_bib4","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1074\/jbc.270.37.22044","article-title":"Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells","volume":"270","author":"Wang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218507_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218507_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1083\/jcb.200512110","article-title":"Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition","volume":"174","author":"Thuault","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218507_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218507_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1101\/gad.293449.116","article-title":"Oncogenic Kras drives invasion and maintains metastases in colorectal cancer","volume":"31","author":"Boutin","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218507_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","article-title":"Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation","volume":"22","author":"Calon","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218507_bib10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(89)90107-4","article-title":"Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes","volume":"58","author":"Harada","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218507_bib11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.1900475","article-title":"Frequent loss of IRF2 in cancers leads to immune evasion through decreased MHC class I antigen presentation and increased PD-L1 expression","volume":"203","author":"Kriegsman","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2026.218507_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218507_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.145","article-title":"MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer","volume":"8","author":"Liang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218507_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2017.12.017","article-title":"Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2","volume":"95","author":"Jin","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218507_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jgh.13041","article-title":"MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients","volume":"31","author":"Chen","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218507_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10620-019-05739-8","article-title":"IRF-2 inhibits gastric cancer invasion and migration by down-regulating MMP-1","volume":"65","author":"Chen","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canlet.2026.218507_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12967-022-03275-0","article-title":"IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer","volume":"20","author":"Chen","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218507_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","article-title":"KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer","volume":"35","author":"Liao","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218507_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41421-021-00312-y","article-title":"A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy","volume":"7","author":"Che","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.canlet.2026.218507_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218507_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218507_bib22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13046-024-03187-5","article-title":"IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomas","volume":"43","author":"Sari","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218507_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/2326-6066.CIR-23-0573","article-title":"An IRF2-Expressing oncolytic virus changes the susceptibility of tumor cells to antitumor T cells and promotes tumor clearance","volume":"12","author":"Shao","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218507_bib24","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1073\/pnas.090099297","article-title":"Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter","volume":"97","author":"Denissova","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218507_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1006\/bbrc.1998.9170","article-title":"Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members","volume":"249","author":"Afrakhte","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218507_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","article-title":"Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation","volume":"6","author":"Kavsak","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218507_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-022-02400-7","article-title":"The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218507_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/onc.2016.260","article-title":"The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition","volume":"36","author":"Battistelli","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218507_bib29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/pcmr.12149","article-title":"GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells","volume":"26","author":"Perrot","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.canlet.2026.218507_bib30","article-title":"IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomas","author":"Sari","year":"2024","journal-title":"Res. Sq"},{"key":"10.1016\/j.canlet.2026.218507_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s13046-021-02191-3","article-title":"The IRF2\/CENP-N\/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis","volume":"40","author":"Qi","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218507_bib32","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.immuni.2022.11.010","article-title":"IRF2 integrates inflammatory signals to balance T cell exhaustion","volume":"55","author":"Sheikh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218507_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(05)80086-8","article-title":"Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development","volume":"75","author":"Matsuyama","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218507_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-04157-w","article-title":"Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial","author":"Yap","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218507_bib35","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1158\/1078-0432.CCR-21-1504","article-title":"First-in-human phase I study of a next-generation, oral, TGFbeta receptor 1 inhibitor, LY3200882, in patients with advanced cancer","volume":"27","author":"Yap","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218507_bib36","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/s41467-024-49221-0","article-title":"MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218507_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104775","article-title":"Immunotherapy in microsatellite-stable colorectal cancer: strategies to overcome resistance","volume":"212","author":"Chen","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:14:03Z","timestamp":1782108843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S0304383526002703"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218507","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGF\u03b2-SMAD2\/3 signaling inhibits IRF2 to drive metastasis in KRAS-mutant colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218507"}}